Abstract:Mitochondria are the energy center of cell operations and are involved in physiological functions and maintenance of metabolic balance and homeostasis in the body. Alterations of mitochondrial function are associated with a variety of degenerative and acute diseases. As mitochondria age in cells, they gradually become inefficient and potentially toxic. Acute injury can trigger the permeability of mitochondrial membranes, which can lead to apoptosis or necrosis. Transactive response DNA-binding protein 43 kDa (TDP-43) is a protein widely present in cells. It can bind to RNA, regulate a variety of RNA processes, and play a role in the formation of multi-protein/RNA complexes. Thus, the normal physiological functions of TDP-43 are particularly important for cell survival. Normal TDP-43 is located in various subcellular structures including mitochondria, mitochondrial-associated membrane, RNA particles and stress granules to regulate the endoplasmic reticulum–mitochondrial binding, mitochondrial protein translation, and mRNA transport and translation. Importantly, TDP-43 is associated with a variety of neurodegenerative diseases, including amyotrophic lateral sclerosis, frontotemporal dementia and Alzheimer's disease, which are characterized by abnormal phosphorylation, ubiquitination, lysis or nuclear depletion of TDP-43 in neurons and glial cells. Although the pathogenesis of TDP-43 proteinopathy remains unknown, the presence of pathological TDP-43 inside or outside of mitochondria and the functional involvement of TDP-43 in the regulation of mitochondrial morphology, transport, and function suggest that mitochondria are associated with TDP-43-related diseases. Autophagy is a basic physiological process that maintains the homeostasis of cells, including targeted clearance of abnormally aggregated proteins and damaged organelles in the cytoplasm; therefore, it is considered protective against neurodegenerative diseases. However, the combination of abnormal TDP-43 aggregation, mitochondrial dysfunction, and insufficient autophagy can lead to a variety of aging-related pathologies. In this review, we describe the current knowledge on the associations of mitochondria with TDP-43 and the role of autophagy in the clearance of abnormally aggregated TDP-43 and dysfunctional mitochondria. Finally, we discuss a novel approach for neurodegenerative treatment based on the knowledge.

Role of Mitophagy in neurodegenerative Diseases and potential tagarts for Therapy

Mitophagy Regulates Neurodegenerative Diseases

Role of mitophagy in mitochondrial quality control: Mechanisms and potential implications for neurodegenerative diseases

Molecular mechanisms of mitophagy and its roles in neurodegenerative diseases

Mitophagy in Neurodegenerative Disease Pathogenesis

Mitophagy regulation in aging and neurodegenerative disease

Mitophagy in Alzheimer’s Disease and Other Age-Related Neurodegenerative Diseases

Mitophagy coordination with retrograde transport ensures the integrity of synaptic mitochondria

Targeting mitophagy for neurological disorders treatment: advances in drugs and non-drug approaches

Mitophagy: An Emerging Role in Aging and Age-Associated Diseases

Mitophagy: A promising therapeutic target for neuroprotection during ageing and age-related diseases

Mitophagy in neurological disorders

Mitophagy and its contribution to metabolic and aging associated disorders.

Regulation and Function of Mitophagy in Development and Cancer

Mitophagy in health and disease. Molecular mechanisms, regulatory pathways, and therapeutic implications

Role of Mitophagy in the Pathogenesis of Stroke: From Mechanism to Therapy

The mitophagy pathway and its implications in human diseases

Maintaining the Balance of TDP-43, Mitochondria, and Autophagy: a Promising Therapeutic Strategy for Neurodegenerative Diseases

Mitochondrial dysfunction as a therapeutic strategy for neurodegenerative diseases: Current Insights and Future Directions

Mitophagy in Human Diseases

Mitophagy in Parkinson’s Disease: From Pathogenesis to Treatment